Trial Profile
ARIXTRA(R) Physician Adherence to the Prescribing Information in Isolated Superficial Vein Thrombosis (SVT) Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 26 Mar 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 18 Apr 2014 Planned End Date changed from 1 Oct 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
- 01 Feb 2013 Actual initiation date changed from May 2012 to Nov 2012 as reported by ClinicalTrials.gov.